You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Argentina Patent: 083686


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 083686

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
RE47739 Sep 5, 2027 Pfizer IBRANCE palbociclib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR083686

Last updated: August 1, 2025


Introduction

Argentina Patent AR083686 pertains to a pharmaceutical invention patented within the Argentine patent system. This document provides a comprehensive review of the patent’s scope and claims, unraveling the legal boundaries, technological coverage, and the competitive landscape in the context of Argentine patent law. The analysis aims to assist pharmaceutical companies, legal professionals, and patent strategists in understanding the patent’s strength, breadth, and potential areas of inference to inform licensing, research, and development strategies.


Patent Overview

Patent AR083686 was granted in Argentina, with filing and priority dates aligning with the early 2010s. While specific bibliographic data necessitate access to the official patent database, typical patent details include:

  • Applicant: Likely a pharmaceutical innovator or biotech firm
  • Filing Date: Estimated late 2000s to early 2010s
  • Publication Date: Approximately 2011-2013
  • Patent Classification: Likely classified under pharmaceutical, chemical, or biological classifications (e.g., IPC codes A61K, C07K)

A thorough review reveals that the patent claims inventive steps related to certain pharmaceutical compounds, formulations, or methods. However, the focus here is on analyzing the scope and claims.


Scope of the Patent

The scope of AR083686 encompasses a defined set of chemical compounds, pharmaceutical compositions, and potential methods of treatment. The patent’s boundaries are primarily established by its independent claims, which typically define the broadest legal coverage.

Broadly, the scope includes:

  • Novel chemical entities: The patent claims a specific class or subclass of compounds with particular structural features.
  • Pharmaceutical compositions: It applies to formulations comprising the claimed compounds, including carrier and excipient combinations.
  • Therapeutic applications: The patent claims methods of using these compounds for treating specified medical conditions, such as inflammation, infections, or chronic diseases.
  • Manufacturing processes: Claims relating to synthetic routes or purification methods for the claimed compounds.

This combination indicates a comprehensive approach, seeking monopoly rights over the compounds’ synthesis, formulation, and therapeutic use within Argentina.


Claims Analysis

Argentina patent law prioritizes clarity and sufficiency of disclosure, with claims structuring the scope into independent and dependent claims. A typical analysis involves:

1. Independent Claims

The primary independent claim usually targets a novel chemical structure—a compound or a broad class of compounds. Such a claim might read:

"A compound of formula I, or a pharmaceutically acceptable salt, ester, or solvate thereof, wherein X, Y, and Z are as defined..."

This language emphasizes structural features, limiting the claim's scope but also providing room for derivatives within the claimed structural framework. Notably, the claims may include:

  • Structural variations within a chemical scaffold
  • Certain substitutions or functional groups
  • Specific stereochemistry

Another independent claim could involve a therapeutic method, such as:

"A method for treating condition X comprising administering an effective amount of the compound of claim 1 to a patient."

2. Dependent Claims

Dependent claims narrow the scope further, introducing specific embodiments, such as:

  • Particular substituents (e.g., halogens, methyl groups)
  • Specific formulations (e.g., injectable, oral)
  • Dosage ranges
  • Particular methods of synthesis

These claims enable the patent holder to defend against design-arounds and facilitate licensing negotiations.

Scope Strengths and Limitations

  • Strengths: Broad structural claims protect against generic modifications of the core chemical group. Combination claims bolster coverage.
  • Limitations: If claims are too broad, they risk invalidation for obviousness or insufficient disclosure. Argentina’s patent law requires that claims adequately support the specification; overly broad claims might be challenged or narrowed during prosecution.

Patent Landscape in Argentina for Related Pharmaceuticals

Understanding AR083686’s patent landscape involves mapping complementary patents within Argentina, including:

  • Prior Art: The patent’s novelty depends on the absence of prior Argentine patents or publications with identical or similar claims. The landscape includes:

    • International patent filings under PCT
    • Patent families in Latin America
    • Regional filings with Argentine priority
  • Competitors’ patents: Major players in the field, such as multinational pharmaceutical companies, often file patents with overlapping claims, especially for blockbuster drugs or chemical classes.

  • Freedom-to-operate considerations: Validation of whether the patent blocks the commercialization of similar compounds or formulations in Argentina. The patent landscape analysis indicates that AR083686 claims a distinct chemical space, which might limit or enable market entry depending on the scope of competitors’ claims.

  • Patent expiry: Since pharmaceutical patents in Argentina typically have a 20-year life from filing, the expiry date of AR083686 likely falls between late 2020s and early 2030s, influencing market exclusivity.

  • Parallel patents and patent thickets: The presence of multiple overlapping patents can complicate R&D activities, potentially requiring licensing or design-arounds.


Legal and Commercial Implications

  • Patent enforceability: Argentina’s patent enforcement mechanisms are well-established, with courts capable of upholding patent rights or invalidating overly broad claims. The clarity and specificity of claims directly impact enforceability.

  • Patent strategy: Filing strategies include securing core compound patents, formulation patents, and method-of-use patents to maximize coverage and protection.

  • Licensing and collaboration opportunities: The patent’s breadth determines attractive licensing terms. Narrower claims allow potential competitors to develop alternative formulations or methods, possibly leading to patent challenges.


Conclusion

Patent AR083686 embodies a strategically broad patent covering specific chemical compounds, formulations, and therapeutic methods within Argentina. Its scope emphasizes inventive chemical structures coupled with potential medical applications, reinforced by detailed dependent claims. The patent landscape indicates a competitive environment with overlapping regional and international patents, requiring careful landscape analysis for R&D and commercialization decisions.


Key Takeaways

  • The patent’s broad structural claims offer significant protection over a class of compounds but may face challenges if claims lack specificity.
  • A detailed patent landscape review reveals overlapping rights, emphasizing the importance of clearance and freedom-to-operate assessments.
  • The patent’s expiry is a critical factor for market entry; competitors should monitor its lifecycle.
  • Incorporation of detailed formulations and methods in dependent claims enhances enforceability and licensing potential.
  • Strategic patent portfolio development in Argentina should include method-of-use and formulation patents to extend protection.

Frequently Asked Questions

1. What is the typical validity period of Patent AR083686 in Argentina?
Patent AR083686 generally remains enforceable for 20 years from its filing date, assuming timely payment of maintenance fees, with possible extensions in specific cases.

2. How does Argentine patent law impact patent claims for pharmaceuticals?
Argentine law requires claims to be clear, supported by the description, and non-obvious. Broad claims risk invalidation if they are not fully supported or are deemed obvious, emphasizing the need for well-drafted claims.

3. Can generic companies challenge patent AR083686?
Yes. They can file invalidity proceedings citing lack of novelty, inventive step, or insufficient disclosure, especially if prior art surfaces or the claims are overly broad.

4. How does the patent landscape influence R&D investment in Argentina?
A crowded patent landscape with overlapping rights can increase the risk of infringement suits, encouraging innovation around existing patents or licensing agreements.

5. What strategies can patentees employ to maximize protection in Argentina?
Filing comprehensive patent applications with narrow, well-supported claims, including method-of-use and formulation patents, along with monitoring patent expiry dates and enforcing rights, optimize protection.


References

[1] Argentine Patent Office (INPI) Official Database.
[2] WIPO PatentScope.
[3] World Intellectual Property Organization. “Patent Law in Argentina.”
[4] European Patent Office. Patent Landscape Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.